Article
Phase 3 Studies of Guadecitabine in AML, MDS/CMML Fail to Meet Primary End Point
Rating:
0.0
Views:
85
Likes:
1
Library:
1
The phase 3 ASTRAL-2 and ASTRAL-3 clinical studies evaluated the efficacy and safety of guadecitabine in adults with previously treated acute myeloid leukemia, and with previously treated myelodysplastic syndromes or chronic myelomonocytic leukemia, respectively.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value